Abraham C.F. Leung
- Oncology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Immunology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Co-authors
- Ian E. KropRon YuAntonio González-Martı́nHans WildiersSung‐Bae KimMelanie C. SmittPatricia LoRussoJean-Marc Ferrero
- Topics
- Cancer Immunotherapy and Biomarkers (6 papers)Immunotherapy and Immune Responses (5 papers)HER2/EGFR in Cancer Research (4 papers)
- Partner nations
- United StatesSpainSouth Korea
In The Last Decade
Abraham C.F. Leung
17 papers receiving 944 citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Oncology 768
- Radiology, Nuclear Medicine and Imaging 326
- Immunology 258
- Pulmonary and Respiratory Medicine 202
- Molecular Biology 199
Countries citing papers authored by Abraham C.F. Leung
This map shows the geographic impact of Abraham C.F. Leung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham C.F. Leung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham C.F. Leung more than expected).
Fields of papers citing papers by Abraham C.F. Leung
This network shows the impact of papers produced by Abraham C.F. Leung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham C.F. Leung. The network helps show where Abraham C.F. Leung may publish in the future.
Co-authorship network of co-authors of Abraham C.F. Leung
This figure shows the co-authorship network connecting the top 25 collaborators of Abraham C.F. Leung. A scholar is included among the top collaborators of Abraham C.F. Leung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abraham C.F. Leung. Abraham C.F. Leung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 32 | |
| 3 | 34 | |
| 4 | 237 | |
| 5 | 1 | |
| 6 | 6 | |
| 7 | 6 | |
| 8 | 6 | |
| 9 | 15 | |
| 10 | 3 | |
| 11 | 16 | |
| 12 | Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trialbreakdown → | 512 |
| 13 | 4 | |
| 14 | 3 | |
| 15 | 34 | |
| 16 | 2 | |
| 17 | Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-alpha-2a. | 40 |
About Abraham C.F. Leung
Abraham C.F. Leung is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 969 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (768 citations), Radiology, Nuclear Medicine and Imaging (326 citations) and Immunology (258 citations). Abraham C.F. Leung has collaborated with scholars based in United States, Spain and South Korea. Frequent co-authors include Ian E. Krop, Ron Yu, Antonio González-Martı́n, Hans Wildiers, Sung‐Bae Kim, Melanie C. Smitt, Patricia LoRusso, Jean-Marc Ferrero, Robert S. Janssen and Joseph J. Drabick. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.